SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-11-031131
Filing Date
2011-05-24
Accepted
2011-05-24 16:03:15
Documents
3
Period of Report
2011-05-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a11-12931_18k.htm 8-K 82819
2 EX-3.1 a11-12931_1ex3d1.htm EX-3.1 11700
3 EX-10.1 a11-12931_1ex10d1.htm EX-10.1 149448
  Complete submission text file 0001104659-11-031131.txt   245335
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23272 | Film No.: 11868117
SIC: 2836 Biological Products, (No Diagnostic Substances)